| Aβ accumulation |
phenotype |
4 |
4 |
amyloid beta accumulation, amyloid beta deposition, amyloid-beta accumulation, beta-amyloid deposition |
| Aβ clearance |
phenotype |
2 |
1 |
beta-amyloid clearance |
| Aβ levels |
phenotype |
2 |
1 |
beta-amyloid levels |
| Aβ production |
phenotype |
2 |
2 |
amyloid beta production, amyloid-beta production, beta-amyloid production |
| B-27 supplement |
drug |
2 |
2 |
B-27 |
| B27 supplement |
drug |
12 |
4 |
B27 |
| Baby boomers |
cohort |
2 |
1 |
Birth cohort 1946-1954, aging baby boomers, born 1946–1954, early baby boomers |
| BAC |
phenotype |
4 |
3 |
BAC, Blood alcohol concentration, blood alcohol concentration, measured BAC, mg/dl |
| Bace1 |
gene |
3 |
— |
Beta-secretase 1, beta-secretase 1, β-Secretase, β-secretase 1 |
| baclofen |
drug |
5 |
5 |
3H-baclofen, Baclofen, GABA B receptor agonist, GABAB receptor agonist |
| Bad Effects |
phenotype |
2 |
— |
|
| BAES |
phenotype |
2 |
2 |
Biphasic Alcohol Effects Scale |
| BAF |
drug |
4 |
2 |
B Allele Frequency, B-allele frequency, BAF complex, BRG1-associated factor, SWI/SNF |
| balance |
phenotype |
3 |
1 |
balance |
| BamHI |
drug |
3 |
— |
|
| barbiturates |
drug |
9 |
8 |
Barbiturates, barbiturates |
| basal activity |
phenotype |
2 |
— |
basal activity of neuronal population |
| baseline assessment |
cohort |
4 |
2 |
baseline, baseline survey |
| basic fibroblast growth factor |
drug |
4 |
2 |
bFGF |
| BAT |
phenotype |
2 |
— |
brown adipose tissue |
